All In Biotech

Drug Trial Radar · NCT02862977

Efficacy and Safety of the Combination of Ketoprofen and Cyclobenzaprine and Caffeine in Osteomuscular Treatment

Phase III, National, Multicenter, Randomized, Double-blind, Double-masked, Compare the Efficacy of Ketoprofen, Cyclobenzaprine and Caffeine Association Versus Cyclobenzaprine and Caffeine (Miosan Caf®) in the Treatment of Osteomuscular Pain in Adults

Last checked: Nov 20, 2026Latest source record: Apr 2, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 414 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

414

Actual

Start

Nov 10, 2017

Primary completion

Jun 5, 2019

Study completion Dec 20, 2019

Sponsor

Lead sponsor
EMSIndustry
Sponsor type
Industry
First posted
Aug 11, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of an association with one anti-inflammatory and one muscle relaxant plus caffeine compared to one anti-inflammatory plus caffeine in the treatment of osteomuscular pain in adults.

Conditions

  • Musculoskeletal Pain

Interventions

  • ketoprofen and cyclobenzaprine association with caffeineDrug

    The patient will take 2 tablets (combination of ketoprofen and cyclobenzaprine and caffeine), oral, per day, each 12h

  • Cyclobenzaprine with caffeineDrug

    The patient will take 2 tablets (combination of cyclobenzaprine and caffeine), oral, per day, each 12h

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy of osteomuscular treatment based on proportion of participants who achieve the 2, 3 or 4 points in the pain scale.Time frame: 48 hours

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Associação dos funcionários públicos do estado do RGS

    Porto Alegre, Rio Grande do Sul, Brazil

  • Centro de Medicina Reprodutiva Dr Carlos Isaia Filho

    Porto Alegre, Rio Grande do Sul, Brazil

  • Allegisa

    Campinas, São Paulo, Brazil

  • CECIP JAU - Centro De Estudos Clinicos do Interior Paulista

    Jaú, São Paulo, Brazil

  • Marcio Antonio Pereira Clinica de Endocrinologia

    São José dos Campos, São Paulo, Brazil

  • AFIP -Associação Fundo de Incentivo a Pesquisa

    São Paulo, São Paulo, Brazil

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.